CSE/BLAB (CSE/BLAB)

Canadian Securities Exchange: CSE/BLAB · CAD

CA$0.07

+0.00 (0.0%)· Recorded snapshot

Market cap	11.5M
Revenue (ttm)	406.4K
Net income (ttm)	16.5M
EPS (ttm)	CA$0.10
Shares out	164.6M
P/E (trailing)	0.7x
Volume	18,350
Beta	0.00

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 406.4K
Net income (ttm): 16.5M
EPS (ttm): CA$0.10
P/E (trailing): 0.7x
Market cap: 11.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E0.7

P25 n/aP50 n/aP75 n/a

ROE108.4

P25 n/aP50 n/aP75 n/a

ROIC-20.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/BLAB indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

CAD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Employees change	0
Employees growth	0%
Enterprise value	CAD -681,260
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA11042D1087
Last earnings date	2026-02-27
Last refreshed	2026-10-28
Last stock split date	2021-11-18
Last stock split type	Reverse
Market cap	CAD 11.5M
Next earnings date	2026-11-27
Price	CAD 0.07
Price currency	CAD
Sector	Healthcare
SIC code	8734
Stock price date	2026-10-27
Symbol	cse/BLAB
Website	https://britannia.life

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	2.96x
Earnings yield	145.63%
FCF / EV yield	57.24%
FCF yield	-3.38%
Graham number	0.55435
Graham upside	691.93%
Lynch fair value	CAD 2.55
Lynch upside	3,540.71%
P/B ratio	0.52x
P/E ratio	0.69x
P/S ratio	28.35x
Price / tangible book value	0.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Effective tax rate	3.28%
Gross margin	22.83%
Operating margin	-357.47%
Pretax margin	3,806.56%
Profit margin	4,069.61%
Profitable quarters	3
Profitable years	2
ROA	-5.24%
ROA (5Y)	-2%
ROCE	-6.52%
ROE	108.44%
ROE (5Y)	-63.09%
ROIC	-20.53%
ROIC (5Y)	-17.91%
Tax / revenue	124.95%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	122.32%
EPS growth (QoQ)	-66.95%
EPS growth 3Y	126.03%
EPS growth 5Y	82.32%
EPS growth quarters	1
EPS growth years	2
Gross profit growth (Q)	-31.33%
Gross profit growth 3Y	-73.55%
Gross profit growth 5Y	-49.14%
Net income growth	122.32%
Net income growth (QoQ)	-66.95%
Net income growth 3Y	120.26%
Net income growth 5Y	102.72%
Net income growth quarters	1
Net income growth years	2
Revenue growth	6.04%
Revenue growth (Q)	-40.29%
Revenue growth (QoQ)	-20.7%
Revenue growth 3Y	-60.99%
Revenue growth 5Y	-34.61%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 62,973
EBIT	CAD -1.5M
EBITDA	CAD -1.4M
EPS	CAD 0.10
FCF per share	CAD -0.00
Financing cash flow	CAD 34,443
Free cash flow	CAD -389,947
Gross profit	CAD 92,795
Income taxes	CAD 507,837
Investing cash flow	CAD 6M
Net borrowing	CAD -105,551
Net cash flow	CAD 5.7M
Net income	CAD 16.5M
Operating income	CAD -1.5M
Revenue	CAD 406,436

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.65
Book value per share	CAD 0.13
Debt / equity	0.01
Interest coverage	-67.07
Long-term assets	CAD 10.4M
Long-term liabilities	CAD 246,531
Net cash (debt)	CAD 12.2M
Net cash / market cap	105.91%
Net cash growth	182.78%
Net debt / equity	-0.55
Piotroski F-Score	3
Property, plant and equipment	CAD 65,121
Shareholders' equity	CAD 22.1M
Tangible book value	CAD 22.1M
Tangible book value per share	CAD 0.13
Total assets	CAD 24.8M
Total cash	CAD 12.4M
Total debt	CAD 211,517
Total liabilities	CAD 2.8M
WACC	4.37%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.02
Current assets	CAD 14.5M
Current liabilities	CAD 2.5M
Current ratio	5.69
Net working capital	CAD -294,215
Quick ratio	5.49
Working capital	CAD 11.9M
Working capital turnover	0.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.08
1D price change	0%
1M price change	7.69%
1M total return	7.69%
1W price change	7.69%
1W total return	7.69%
1Y price change	-26.32%
1Y return CAGR	-26.33%
1Y total return	-26.32%
20-day SMA	CAD 0.07
200-day SMA	CAD 0.08
3M price change	7.69%
3M total return	7.69%
3Y price change	7.69%
3Y return CAGR	2.5%
3Y total return	7.69%
50-day SMA	CAD 0.07
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.11
52-week high date	2026-03-10
52-week low	CAD 0.06
52-week low date	2026-10-02
6M price change	-22.22%
6M total return	-22.22%
All-time high	CAD 0.32
All-time high date	2021-11-18
All-time low	CAD 0.03
All-time low date	2023-12-05
Average true range (ATR)	CAD 0.00
Average volume	89.8K
Beta (1Y)	-1.43
Beta (2Y)	-1.34
Beta (5Y)	0
Change from 52-week high	-36.36%
Change from 52-week low	16.67%
Change from all-time high	-78.13%
Change from all-time low	133.33%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 1,285
High price	CAD 0.07
Low price	CAD 0.07
Monthly RSI	45.78
Open price	CAD 0.07
Previous close	CAD 0.07
Price vs 150-day SMA	-14.63%
Price vs 20-day SMA	5.58%
Price vs 200-day SMA	-17.26%
Price vs 50-day SMA	4.01%
Relative volume	0.2
RSI	60.12
Sharpe ratio	0.46
Sharpe ratio (3Y)	0.68
Sortino ratio	0.81
Sortino ratio (3Y)	1.19
Volume	18.4K
Weekly RSI	46.09
YTD price change	-22.22%
YTD total return	-22.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	100.7M
Shares change (QoQ)	0%
Shares held by insiders	38.82%
Shares outstanding	164.6M

Deeper analysis on CSE/BLAB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/BLAB report

Is a complete CSE/BLAB research report available?

No complete published report is available for cse/BLAB (CSE/BLAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/BLAB (CSE/BLAB)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/BLAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/BLAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on CSE/BLAB

Frequently asked questions